The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook
Journal of Nuclear Medicine · 2024
DOI: 10.2967/jnumed.123.266978 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Xiangxi Meng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), National Medical Products Association, Key Laboratory fo…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Drug Development, Whole Body Imaging. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
Total-body PET, an emerging technique, enables high-quality simultaneous total-body dynamic PET acquisition and accurate kinetic analysis. It has the potential to facilitate the study of multiple tracers while minimizing radiation dose and improving tracer-specific imaging. This advancement holds promise for enhancing the development and clinical evaluation of drugs, particularly radiopharmaceuticals. Multiple clinical trials are using a total-body PET scanner to explore existing and innovative radiopharmaceuticals. However, challenges persist, along with the opportunities, with regard to the use of total-body PET in drug development and evaluation. Specifically, considerations relate to the role of total-body PET in clinical pharmacologic evaluations and its integration into the theranostic paradigm. In this review, state-of-the-art total-body PET and its potential roles in pharmaceutical research are explored.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), National Medical Products Association, Key Laboratory for Research and Evaluation of Radiopharmaceuticals, National Medical Pr…
- Beijing United Imaging Research Institute of Intelligent Imaging, Beijing, China.
Zitieren
APA
Meng, X., Kong, X., Xia, L., Wu, R., Zhu, H., & Yang, Z. (2024). The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.266978
Vancouver
Meng X, Kong X, Xia L, Wu R, Zhu H, Yang Z. The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.123.266978
BibTeX
@article{Meng2024,
author = {Meng, Xiangxi and Kong, Xiangxing and Xia, Lei and Wu, Runze and Zhu, Hua and Yang, Zhi},
title = {The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook},
journal = {Journal of Nuclear Medicine},
year = {2024},
doi = {10.2967/jnumed.123.266978}
}
EUVIMED